{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:24:19Z","timestamp":1789043059242,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ricerca Finalizzata Ministero della Salute","award":["RF-2021-12374029"],"award-info":[{"award-number":["RF-2021-12374029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>\u03b1-Synuclein is an essential component of synucleinopathies including Parkinson disease, dementia with Lewy bodies, and multiple system atrophy (MSA). Misfolded-\u03b1-synuclein inclusions that contain high levels of Serine-129 phosphorylated (pS129-\u03b1-syn) are key diagnostic markers. Skin biopsies are a promising peripheral tissue for in vivo detection of aggregates using immunofluorescence staining. Several primary antibodies target pS129-\u03b1-syn but their diagnostic reliability remains uncertain. Common practice relies on clones EP1536Y and 81A without antigen retrieval; however, recent findings have underscored the need to validate additional methodologies and alternative clones. We compared the diagnostic accuracy of the standard protocol, alongside formic acid and proteinase K (PK) antigen retrieval to evaluate 4 additional monoclonal antibodies (J18, BBF19, pSyn#64, and D1R1R) in a cohort of 43 confirmed synucleinopathy patients (7 with MSA) and 33 healthy controls. The results showed that PK increased the detection rates for EP1536Y, 81A, and D1R1R, with D1R1R outperforming the others in sensitivity. J18, BBF19, and pSyn#64 exhibited insufficient specificity, limiting their clinical applicability. The improved accuracy with PK treatment and the promising performance of D1R1R mark critical advancements for reliable diagnosis, highlighting the importance of optimizing protocols and validating antibodies for dependable detection of pathological aggregates in skin biopsies.<\/jats:p>","DOI":"10.1093\/jnen\/nlaf036","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:25:10Z","timestamp":1745328310000},"page":"715-724","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of 6 monoclonal antibodies against Ser129-phosphorylated \u03b1-synuclein: Critical role of proteinase K antigen retrieval and superior sensitivity of the D1R1R clone in human skin biopsies"],"prefix":"10.1093","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2620-854X","authenticated-orcid":false,"given":"Cecilia","family":"Delprete","sequence":"first","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Incensi","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Furia","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]},{"name":"Dipartimento di Scienze Biomediche e Neuromotorie, Universit\u00e0 di Bologna , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bari","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]},{"name":"Dipartimento di Scienze Biomediche e Neuromotorie, Universit\u00e0 di Bologna , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-7318","authenticated-orcid":false,"given":"Vincenzo","family":"Donadio","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Neuromuscular and Neuroimmunology Unit, Bellaria Hospital , Bologna,","place":["Italy"]},{"name":"Dipartimento di Scienze Biomediche e Neuromotorie, Universit\u00e0 di Bologna , Bologna,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025072103523184500_nlaf036-B1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","article-title":"The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy","volume":"920","author":"Spillantini","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"2025072103523184500_nlaf036-B2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"2025072103523184500_nlaf036-B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci Lett"},{"key":"2025072103523184500_nlaf036-B4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnen\/nlae015","article-title":"Skin nerve phosphorylated a-synuclein in the elderly","volume":"83","author":"Donadio","year":"2024","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025072103523184500_nlaf036-B5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","article-title":"Low sensitivity in clinical diagnoses of dementia with Lewy bodies","volume":"257","author":"Nelson","year":"2010","journal-title":"J Neurol"},{"key":"2025072103523184500_nlaf036-B6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12046","article-title":"\u03b1-Synuclein: the long distance runner","volume":"23","author":"George","year":"2013","journal-title":"Brain Pathol"},{"key":"2025072103523184500_nlaf036-B7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2024.0792","article-title":"Skin biopsy detection of phosphorylated \u03b1-synuclein in patients with synucleinopathies","volume":"331","author":"Gibbons","year":"2024","journal-title":"JAMA"},{"key":"2025072103523184500_nlaf036-B8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.0b013e3182825127","article-title":"Skin sympathetic fiber \u03b1-synuclein deposits: a potential biomarker for pure autonomic failure","volume":"80","author":"Donadio","year":"2013","journal-title":"Neurology"},{"key":"2025072103523184500_nlaf036-B9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"2025072103523184500_nlaf036-B10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","article-title":"A new potential biomarker for dementia with Lewy bodies: skin nerve \u03b1-synuclein deposits","volume":"89","author":"Donadio","year":"2017","journal-title":"Neurology"},{"key":"2025072103523184500_nlaf036-B11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.24567","article-title":"Skin nerve misfolded \u03b1-synuclein in pure autonomic failure and Parkinson disease","volume":"79","author":"Donadio","year":"2016","journal-title":"Ann Neurol"},{"key":"2025072103523184500_nlaf036-B12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2025072103523184500_nlaf036-B13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neulet.2009.12.027","article-title":"Clinical availability of skin biopsy in the diagnosis of Parkinson\u2019s disease","volume":"469","author":"Miki","year":"2010","journal-title":"Neurosci Lett"},{"key":"2025072103523184500_nlaf036-B14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025072103523184500_nlaf036-B15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cger.2021.01.002","article-title":"Small fiber neuropathy in the elderly","volume":"37","author":"Zhou","year":"2021","journal-title":"Clin Geriatr Med"},{"key":"2025072103523184500_nlaf036-B16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2025072103523184500_nlaf036-B17","doi-asserted-by":"crossref","first-page":"31224","DOI":"10.1074\/jbc.M114.559237","article-title":"Interplay between sumoylation and phosphorylation for protection against \u03b1-synuclein inclusions","volume":"289","author":"Shahpasandzadeh","year":"2014","journal-title":"J Biol Chem"},{"key":"2025072103523184500_nlaf036-B18","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J Biol Chem"},{"key":"2025072103523184500_nlaf036-B19","doi-asserted-by":"crossref","first-page":"134899","DOI":"10.1016\/j.neulet.2020.134899","article-title":"Generation of monoclonal antibodies against phosphorylated \u03b1-synuclein at serine 129: research tools for synucleinopathies","volume":"725","author":"Fayyad","year":"2020","journal-title":"Neurosci Lett"},{"key":"2025072103523184500_nlaf036-B20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-016-0357-9","article-title":"Novel antibodies to phosphorylated \u03b1-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes","volume":"4","author":"Rutherford","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2025072103523184500_nlaf036-B21","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"2025072103523184500_nlaf036-B22","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cne.24468","article-title":"Sensitivity and specificity of phospho-Ser129 \u03b1-synuclein monoclonal antibodies","volume":"526","author":"Delic","year":"2018","journal-title":"J Comp Neurol"},{"key":"2025072103523184500_nlaf036-B23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-016-0072-9","article-title":"Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson\u2019s disease","volume":"11","author":"Majbour","year":"2016","journal-title":"Mol Neurodegener"},{"key":"2025072103523184500_nlaf036-B24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/d41586-020-02549-1","article-title":"When antibodies mislead: the quest for validation","volume":"585","author":"Baker","year":"2020","journal-title":"Nature"},{"key":"2025072103523184500_nlaf036-B25","doi-asserted-by":"crossref","first-page":"1794421","DOI":"10.1080\/19420862.2020.1794421","article-title":"The Antibody Society\u2019s antibody validation webinar series","volume":"12","author":"Voskuil","year":"2020","journal-title":"MAbs"},{"key":"2025072103523184500_nlaf036-B26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JPD-213085","article-title":"Specific detection of physiological S129 phosphorylated \u03b1-synuclein in tissue using proximity ligation assay","volume":"13","author":"Arlinghaus","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"2025072103523184500_nlaf036-B27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnen\/nly074","article-title":"Skin nerve phosphorylated a-synuclein deposits in Parkinson disease with orthostatic hypotension","volume":"77","author":"Donadio","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025072103523184500_nlaf036-B28","doi-asserted-by":"crossref","first-page":"569446","DOI":"10.3389\/fneur.2020.569446","article-title":"Optimization of the detection method for phosphorylated \u03b1-synuclein in Parkinson disease by skin biopsy","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol"},{"key":"2025072103523184500_nlaf036-B29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2019.03.003","article-title":"The aggregation state of \u03b1-synuclein deposits in dermal nerve fibers of patients with Parkinson\u2019s disease resembles that in the brain","volume":"64","author":"Kuzkina","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2025072103523184500_nlaf036-B30","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/acn3.50833","article-title":"Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients","volume":"6","author":"Antelmi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2025072103523184500_nlaf036-B31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fneur.2018.01094","article-title":"Dermal phospho-alpha-synuclein deposition in patients with Parkinson\u2019s disease and mutation of the glucocerebrosidase gene","volume":"9","author":"Doppler","year":"2018","journal-title":"Front Neurol"},{"key":"2025072103523184500_nlaf036-B32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","article-title":"Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity","volume":"8","author":"Lashuel","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"2025072103523184500_nlaf036-B33","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"2025072103523184500_nlaf036-B35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B36","doi-asserted-by":"crossref","first-page":"E2513","DOI":"10.1212\/WNL.0000000000011935","article-title":"In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC","volume":"96","author":"Donadio","year":"2021","journal-title":"Neurology"},{"key":"2025072103523184500_nlaf036-B37","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1038\/s41598-018-32588-8","article-title":"Skin \u03b1-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study","volume":"8","author":"Donadio","year":"2018","journal-title":"Sci Rep"},{"key":"2025072103523184500_nlaf036-B38","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/ene.13939","article-title":"Abnormal \u03b1-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility","volume":"26","author":"Donadio","year":"2019","journal-title":"Eur J Neurol"},{"key":"2025072103523184500_nlaf036-B39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/brain\/awac124","article-title":"Phosphorylated \u03b1-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy","volume":"146","author":"Donadio","year":"2023","journal-title":"Brain"},{"key":"2025072103523184500_nlaf036-B40","doi-asserted-by":"crossref","first-page":"e202-5","DOI":"10.1111\/j.1365-2982.2012.01887.x","article-title":"A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease","volume":"24","author":"Pouclet","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"2025072103523184500_nlaf036-B41","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/jcm8101601","article-title":"Plasma ps129-\u03b1-synuclein is a surrogate biofluid marker of motor severity and progression in Parkinson\u2019s disease","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"2025072103523184500_nlaf036-B42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/hvab251","article-title":"High-sensitivity single molecule array assays for pathological isoforms in Parkinson\u2019s disease","volume":"68","author":"Norman","year":"2022","journal-title":"Clin Chem"},{"key":"2025072103523184500_nlaf036-B43","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fnins.2019.00889","article-title":"Phospho-S129 alpha-synuclein is present in human plasma but not in cerebrospinal fluid as determined by an ultrasensitive immunoassay","volume":"13","author":"Cariulo","year":"2019","journal-title":"Front Neurosci"},{"key":"2025072103523184500_nlaf036-B44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.28126","article-title":"Skin biopsy may help to distinguish multiple system atrophy\u2013parkinsonism from Parkinson\u2019s disease with orthostatic hypotension","volume":"35","author":"Donadio","year":"2020","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.28399","article-title":"Immunohistochemical detection of synuclein pathology in skin in idiopathic rapid eye movement sleep behavior disorder and parkinsonism","volume":"36","author":"Al-Qassabi","year":"2021","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JPD-212904","article-title":"Presence of skin \u03b1-synuclein deposits discriminates Parkinson\u2019s disease from progressive supranuclear palsy and corticobasal syndrome","volume":"12","author":"Giannoccaro","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"2025072103523184500_nlaf036-B47","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.26293","article-title":"Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy","volume":"30","author":"Doppler","year":"2015","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B48","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/mds.27794","article-title":"Value of in vivo \u03b1-synuclein deposits in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"34","author":"Tsukita","year":"2019","journal-title":"Mov Disord"},{"key":"2025072103523184500_nlaf036-B49","first-page":"2","article-title":"The search for a peripheral biopsy indicator of a-synuclein pathology for Parkinson disease","volume":"76","author":"Lee","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025072103523184500_nlaf036-B50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1369\/0022155420960250","article-title":"Phosphorylated alpha-synuclein within cutaneous autonomic nerves of patients with parkinson\u2019s disease: the implications of sample thickness on results","volume":"68","author":"Wang","year":"2020","journal-title":"J Histochem Cytochem"},{"key":"2025072103523184500_nlaf036-B51","doi-asserted-by":"crossref","first-page":"104076","DOI":"10.1016\/j.ebiom.2022.104076","article-title":"Skin alpha-synuclein deposit patterns: a predictor of Parkinson\u2019s disease subtypes-NC-ND license","volume":"80","author":"Han","year":"2022","journal-title":"EBioMedicine"},{"key":"2025072103523184500_nlaf036-B52","doi-asserted-by":"crossref","first-page":"120730","DOI":"10.1016\/j.jns.2023.120730","article-title":"Alpha-synuclein in skin as a high-quality biomarker for Parkinson\u2019s disease","volume":"451","author":"Peng","year":"2023","journal-title":"J Neurol Sci"},{"key":"2025072103523184500_nlaf036-B53","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JPD-150670","article-title":"Optimizing Western blots for the detection of endogenous \u03b1-synuclein in the enteric nervous system","volume":"5","author":"Preterre","year":"2015","journal-title":"J Parkinsons Dis"},{"key":"2025072103523184500_nlaf036-B54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"2025072103523184500_nlaf036-B55","doi-asserted-by":"crossref","first-page":"42984","DOI":"10.1038\/srep42984","article-title":"\u03b1-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson\u2019s disease patients","volume":"7","author":"Dieriks","year":"2017","journal-title":"Sci Rep"},{"key":"2025072103523184500_nlaf036-B56","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025072103523184500_nlaf036-B57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-017-0452-6","article-title":"Mechanisms underlying extensive Ser129-phosphorylation in \u03b1-synuclein aggregates","volume":"5","author":"Arawaka","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2025072103523184500_nlaf036-B58","doi-asserted-by":"crossref","first-page":"e14354","DOI":"10.1111\/nmo.14354","article-title":"Comparison of commercially available antibodies for the detection of phosphorylated alpha-synuclein in primary culture of ENS","volume":"34","author":"Lassoz\u00e9","year":"2022","journal-title":"Neurogastroenterol Motil"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/8\/715\/62987271\/nlaf036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/8\/715\/62987271\/nlaf036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T07:52:45Z","timestamp":1753084365000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/84\/8\/715\/8117857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":58,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlaf036","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,22]]}}}